Thirty weeks, around sixty thousand readings, a sensor on my arm. This page shows how my values developed over that time — including the weeks when things went backwards.
This is the record of a single case, not a set of instructions. Whether and how medication is used is decided by your doctor together with you. Never stop taking medication on your own. What worked for me may turn out differently for you — type 2 varies from person to person, and many people need medication without having done anything wrong.
Thirty weeks in figures
Calculated from the raw sensor export. Around 2,000 readings per week.
What the curve shows
The weekly average fell from 143 to 118 mg/dl. The glucose management indicator, a calculated approximation of the long-term value, went from 6.7 to 6.1 per cent.
What matters more to me than the final figure: the line is not straight. It has spikes, and one of them was pronounced.
Week five
In calendar week five the average sat at 163 mg/dl — higher than any other week of the year. Only 45 per cent of readings fell between 70 and 160; usually it was 90 and above.
I still do not know exactly why. It was winter, I moved little, and everyday life was full. Probably several things came together. What I did not do: delete the week from the record.
Showing only the good stretches creates a false picture. Anyone managing a metabolic condition without medication will have weeks where the numbers rise. The question is not whether that happens, but what comes next.
What I changed
Three things, over months, without perfection:
Movement after meals. Twenty minutes of walking whenever possible. That is the lever with the best ratio of effort to effect — at least for me.
Regular training. Steady endurance work plus strength sessions. Not daily, but reliably.
Dinner earlier and lower in carbohydrates. Not always practical. When it works, I see it the next morning.
What I did not do
I did not go hungry, skip meals or follow any named diet. I also did not use supplements as a substitute for anything else.
And I stopped nothing — that question never arose in my case. Anyone taking medication should walk this path with medical support, not against it.
Established: over these thirty weeks my values fell. The measurement is continuous and the figures come from the raw sensor export.
Not established: which measure contributed how much. I changed several things at once, and season, stress and sleep played their part. Separating the factors would require conditions that everyday life does not offer.
Also not established: that this pattern looks similar for others. One case is one case.
On the word remission
In the literature, remission in type 2 means the long-term value stays below a defined threshold without medication for at least three months. It does not mean cure. The predisposition remains, and values can return — particularly when circumstances change.
Whether my situation meets that definition is not something the sensor determines. That requires a medical assessment with laboratory values. The sensor shows a direction, not a diagnosis.
Key points
- Thirty weeks of continuous measurement, around 60,000 individual readings.
- Weekly average fell from 143 to 118 mg/dl.
- The calculated long-term value went from 6.7 to 6.1 per cent.
- One week sat well above the rest — setbacks are part of it.
- Which factor contributed what cannot be separated.
- Medication belongs in medical hands, not self-management.
Single-case record, not a study and not a recommendation.
The original measurement record remains unchanged. This section adds only method, sources, limitations and a reproducible follow-up plan.
The central question in this article
The article “Living with type 2 without medication: thirty weeks of sensor data” examines how thirty weeks of sensor data without diabetes medication can be described without turning it into a treatment recommendation. The quality test is not whether one curve creates a compelling story. It is whether the timeline, data source, surrounding circumstances and alternative explanations are documented well enough for readers to separate observation from interpretation.
What the data show — and what they do not
A personal series can show timing and recurring patterns. It cannot by itself prove which physiological mechanism caused the pattern. Direct observation, plausible explanation and open question are therefore separated. Numbers remain linked to unit, time and data source, and missing details are not replaced with guesses.
Reading CGM correctly
Continuous glucose monitoring measures interstitial glucose. During rapid rises or falls, the display may follow blood glucose with a delay. Pressure on the sensor, a newly inserted sensor, hydration and short data gaps can add uncertainty. When a reading does not match symptoms or the situation, a confirmatory measurement may be appropriate depending on the clinical significance.
Technical context: CGM data and long-term patterns
A CGM measures glucose in interstitial fluid rather than directly in blood. During rapid change, sensor glucose and blood glucose may differ. Compression, newly inserted sensors, gaps and technical interruptions therefore need to remain visible. Long-term data are more credible when coverage and downtime are reported alongside averages. A month with only a few sensor days is not automatically comparable with a nearly complete month. Outliers should neither be removed without a rule nor presented dramatically without context.
Article-specific interpretation
For “Living with type 2 without medication: thirty weeks of sensor data”, this means first establishing which of the four phases — Check data coverage, Mark measurement quality, Calculate metrics, Add context and limits — are actually documented. A missing phase is not guessed from the curve. This matters especially because how thirty weeks of sensor data without diabetes medication can be described without turning it into a treatment recommendation. More decimal places do not improve research; more complete context does.
Alternative explanations
The competing influences considered are Sensor age and change, Data gaps, Time of day and events, Aggregation and outliers. Several can act at once and partly mask one another. No factor is therefore declared causal merely because it occurred close in time. A plausible explanation remains labelled as plausible until a targeted comparison supports it.
Data sheet and provenance
The data sheet for “Living with type 2 without medication: thirty weeks of sensor data” records more than the start and peak. It also covers Check data coverage, Mark measurement quality, Calculate metrics and Add context and limits. Each section states whether a value was measured directly, read from a screenshot, calculated from raw data or reconstructed from memory. This keeps strong research separate from details that require later verification.
Typical failure modes
Common failure modes in this topic are incomplete portions, an incorrect time origin, events added retrospectively and observation ending too soon. For “Living with type 2 without medication: thirty weeks of sensor data”, Sensor age and change and Time of day and events are particularly important competing explanations. A finding is therefore given more weight only when the same direction appears on several sufficiently similar days and counterexamples are documented as well.
Editorial decision
The editorial decision is to keep the personal experience visible without turning it into universal advice. Headline, hero image, alternative text, captions and conclusion must communicate the same uncertainty. When the article contains an open question, it ends with the next testable step — Preserve raw data — rather than a claim of effect.
Interpretation matrix
The interpretation matrix for “Living with type 2 without medication: thirty weeks of sensor data” assigns every core statement to one of four classes: directly measured, calculated from several readings, physiologically plausible or still open. Direct measurement does not automatically establish causation. A calculated result requires a documented formula and time window. Plausible means consistent with physiology and timing but not isolated in the personal data. Open means that data, repetitions or comparison conditions are missing.
Publication review
Before publication, a final review asks whether the hero image matches the actual message of “Living with type 2 without medication: thirty weeks of sensor data”, whether every number can be found in the text, whether units and timing are correct, and whether every image has alternative text and a caption. It also checks that Sensor age and change or Data gaps has not accidentally been turned into a proven cause. Only then is the article editorially complete.
Reproducible follow-up plan
The next useful comparison follows four steps: Preserve raw data, Flag incomplete days, Use the same metrics, Export reproducibly. This sequence turns a spontaneous observation into a protocol and reduces the risk of selecting only spectacular days while forgetting ordinary patterns.
What can be transferred
The transferable lesson from “Living with type 2 without medication: thirty weeks of sensor data” is therefore not necessarily the exact number. What transfers are the question, the documented conditions and the handling of uncertainty. Other people may respond very differently because of treatment, fitness, insulin sensitivity, digestion or comorbidity.
Comparison rather than snapshot
A credible comparison starts with one clear question and conditions that are as similar as possible. Starting value, trend, time, portion, drinks, activity, sleep, stress and medication all belong in the record. Not every factor can be controlled; the important point is to show differences rather than explain them away afterwards.
State the observation window
Thirty minutes answers a different question from two, four or twelve hours. The article therefore states when observation begins and recognises that mixed meals, alcohol or intense activity can act later. A peak is not interpreted without the pattern before and after it.
Personal readings are not universal limits
Typical guideline targets can provide orientation but require individualisation. Age, comorbidities, pregnancy, medication, hypoglycaemia risk and personal treatment goals change the interpretation. The self-observations shown here do not replace diagnosis or treatment decisions.
Practical safety framework
Marked symptoms, recurrent hypoglycaemia, very high readings, ketones or a pattern that does not fit the situation require clinical assessment rather than another self-experiment. People using insulin or glucose-lowering medication must not derive dose changes or corrections from a blog post.
Further technical limitations
Metrics such as mean glucose, variability, time in an individually defined range and coverage answer different questions. They do not replace laboratory values or clinical assessment. In particular, remission cannot be established from a CGM chart alone. A reproducible analysis records export date, time zone, sensor version, filtering rules and calculation method. This is the only way to explain later why two analyses of similar raw data may differ.
Questions before drawing a conclusion
- Is the starting value for “Living with type 2 without medication: thirty weeks of sensor data” documented with trend and time?
- Are Sensor age and change and Data gaps described adequately?
- Did observation continue through “Add context and limits”?
- Is there a comparison day after “Preserve raw data”?
- Is each statement clearly labelled as personal, plausible or generally established?
Sources and context
- American Diabetes Association: Standards of Care in Diabetes—2026, glycaemic goals
- American Diabetes Association: Standards of Care in Diabetes—2026, diabetes technology
- NIDDK: Healthy Living with Diabetes
- Abbott: difference between interstitial and blood glucose
- American Diabetes Association: Standards of Care in Diabetes—2026, health behaviours and exercise
Medical notice: This article explains a personal observation and general context. It does not replace diagnosis, treatment adjustment or emergency care.
Sources
This entry is based on my own sensor readings. Where studies are mentioned, they are linked in the text. Continuous glucose monitoring: FreeStyle Libre 3.
Thirty calendar weeks, not thirty uninterrupted sensor weeks
The reviewed period spans 30 calendar weeks and 195 actual sensor days. The long-term line is a trend across measured phases, not uninterrupted monitoring. Future summaries will state this distinction directly.